VJOncology is committed to improving our service to you

BOPA 2018 | Update from the Scottish Cancer Medicines Outcome Programme

VJOncology is committed to improving our service to you

Kelly Baillie

Kelly Baillie, of the NHS Greater Glasgow & Clyde, Glasgow, UK, presents the key findings from the Cancer Medicines Outcome Programme, a collaboration between NHS Greater Glasgow and Clyde and the University of Strathclyde with the aim of investigating whether medicines are as effective in real world populations, as they are in clinical trials. Looking specifically at men who received abiraterone and enzalutamide for the treatment of metastatic, castration-resistant prostate cancer, this initiative used electronic record linkage to combine the chemotherapy prescribing system with other useful patient information. At the British Oncology Pharmacy Association (BOPA) Annual Symposium 2018, held in Birmingham, UK, Ms Baillie shares the results of this retrospective study.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter